byiShook Opinion
Oct 14, 2024 - 13:35
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock. The post Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade appeared first on Investor's Business Daily.
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock.
The post Why Amgen's Obesity Drug â And $5 Billion Opportunity â Led To A Downgrade appeared first on Investor's Business Daily.